More Medtronic Shareholders Sue Company Over Downplaying Infuse Bone Risks

More and more patients are claiming that Medtronic’s Infuse Bone Growth doesn’t work and carries serious side effects. While patient lawsuits against the company are mounting, Medtronic shareholders are also angry. In a recently filed lawsuit, they claim that the company knew about the issues, but downplayed them to inflate stock prices.

Medtronic Concealed Known Facts – From Everyone

Minnesota based Medtronic, a global medical device company, has seen its share of scandals. In 2007, Medtronic’s Sprint Fidelis defibrillator lead wires were recalled after it was discovered that the wires could fracture or break, resulting in unnecessary electrical shocks, device failure or death. In 2011, the company paid over $23 million to settle allegations that it paid doctors substantial kickbacks to use its products.

Medtronic now faces numerous lawsuits from patients and stockholders who are saying that the company concealed known facts about serious Infuse Bone growth side effects, including severe and chronic pain, male sterility, cancer, infection, and bone loss – all of which can result in substantial medical bills, pain and suffering, lost income and more.

According to Mass Device, the latest shareholder lawsuit accuses the company and some of its officers of “knowingly downplaying possible dangers of the Infuse product in order to artificially inflate stock prices and [making] misleading statements about Infuse and its use in pain management and degenerative disc disease treatment.”

Put Our Experience To Work For You

If you’ve been injured by Medtronic’s Infuse Bone Growth, contact The Driscoll Firm, LLC, and let our experienced and aggressive team of product liability attorneys review your case and determine whether you might be entitled to damages for lost income, medical bills, pain and suffering and more. We’ve recovered over $170 million for our clients. Let us put our experience to work for you.

Benefactor of Public Justice